TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Delek Logistics Reports First Quarter 2026 Results
Agios Reports First Quarter 2026 Financial Results and Provides Business Update
Delek US Holdings Reports First Quarter 2026 Results
Costamare Inc. Reports Results For The First Quarter Ended March 31, 2026
GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth
GE HealthCare reports first quarter 2026 financial results
BRINKER INTERNATIONAL REPORTS THIRD QUARTER OF FISCAL 2026 RESULTS AND UPDATES FISCAL 2026 GUIDANCE
[Press Release] HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for wAIHA
Court rejected a motion for a class action regarding the deposit of deposits by remote means - continuation